Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2026 13:30 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1)

CHMP has adopted a positive opinion, recommending marketing authorisation of Wegovy® 7.2 mg in a single-dose pen for people living with obesity.